Swagatam Mukhopadhyay

This paper introduces a CNN classifier for therapeutic peptide classification using augmented negative sampling, achieving significantly lower false positive rates and competitive performance on external benchmarks.

The paper develops a dose-response model and analysis tool to accurately quantify gene knockdown effects of oligonucleotide-based medicines using next-generation sequencing data.